Mannatech (NASDAQ:MTEX) Coverage Initiated at StockNews.com

Equities research analysts at StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX) in a report issued on Tuesday. The firm set a “buy” rating on the stock.

Mannatech Price Performance

MTEX stock opened at $7.88 on Tuesday. The company has a quick ratio of 0.74, a current ratio of 1.25 and a debt-to-equity ratio of 0.44. The stock’s 50 day moving average is $7.83 and its two-hundred day moving average is $7.56. The company has a market capitalization of $14.81 million, a PE ratio of -9.73 and a beta of 1.17. Mannatech has a 52-week low of $6.75 and a 52-week high of $10.51.

Mannatech (NASDAQ:MTEX) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($0.17) EPS for the quarter. The company had revenue of $31.73 million for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%.

Insider Activity

In related news, Director Larry A. Jobe sold 16,288 shares of Mannatech stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $7.75, for a total transaction of $126,232.00. Following the sale, the director now directly owns 54,721 shares in the company, valued at $424,087.75. The trade was a 22.94 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 41.50% of the company’s stock.

About Mannatech

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.